Navigation Links
Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
Date:7/18/2014

assessments made in light of AbbVie's or, as the case may be, Shire's experience and perception of historical trends, current conditions, business strategies, operating environment, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this announcement could cause AbbVie's plans with respect to Shire, AbbVie's or Shire's actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this announcement are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. Additional information about economic, competitive, governmental, technological and other factors that may affect AbbVie is set forth in Item 1A, "Risk Factors," in AbbVie's 2013 Annual Report on Form 10-K, which has been filed with the SEC, the contents of which are not incorporated by reference into, nor do they form part of, this announcement. Neither AbbVie nor Shire undertakes any obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.

Publication of this announcementA copy of this announcement will be available on www.abbvieinvestor.com and www.shire.com.

The contents of AbbVie's website and Shire's website are not incorporated into and do not form part of th
'/>"/>

SOURCE AbbVie Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
2. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
3. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
4. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
5. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
6. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
7. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
8. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
9. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
10. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
11. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... -- The Judicial Panel on Multidistrict Litigation (JPML) will ... Inferior vena cava (IVC) Filter lawsuits filed against C.R. ... already been centralized by the JPML. "IVC ... for a pulmonary embolism. The filters are designed to ... against Bard and Cook involve incidents of retrievable IVC ...
(Date:7/29/2015)... Mass. , July 29, 2015 ... an investor presentation August 6, 2015 at 10:45 ... Robert Clarke , Chief Executive Officer, will review ... the Company,s pipeline of inhaled therapeutics based on ... Date:     Thursday, August 6, 2015 Time:    ...
(Date:7/29/2015)... 29, 2015  Fifty groups representing 500,000 patients, doctors, ... to launch the AllTrials campaign in the US. The ... and future, to be registered and the results from ... Ben Goldacre explains: "Patients want the treatments that ... on what works. Unfortunately, we now know that around ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2Pulmatrix to Webcast Investor Presentation and Provide Update on Pipeline of Inhaled Therapeutics August 6th 2Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... Ga., Sept. 28, 2011 Kimberly-Clark Health Care (KCHC) ... the Food and Drug Administration (FDA) to market the ... that the FDA has granted any manufacturer 510(k) clearance ... with the designation of a Class II medical device. ...
... Visionsense Corp announces an unique milestone this week when ... procedure with the VSii system. Dr. ... of Neurosurgery at Emory University and Professor of Neurosurgery ... pituitary adenoma in the morning of September 22nd, 2011 ...
Cached Medicine Technology:Kimberly-Clark Health Care Receives Landmark FDA Clearance for Pediatric Face Mask 2
(Date:7/29/2015)... ... July 29, 2015 , ... Topical BioMedics, Inc., announces ... Relief and Healing Cream designated as the nonprofit’s natural pain reliever of choice.     ... Line of Duty Deaths (LODD) and the high rate of pain and injuries ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami ... or alcohol addiction and mental health disorders. Acu-detox may begin taking off in the ... from drug and alcohol addiction. Although acupuncture is not a new practice, it is ...
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year ... featured in the list of the 50 fastest growing companies in Jacksonville. This annual ... business community. On July 16th, a team of Vast Bridges staffers were on hand ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline Publications, Inc., will ... on RFD-TV. , Fastline is dedicated to quality agricultural advertising, both in print ... largest and freshest searchable agriculture equipment database in the world. The site has ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Employee Fiduciary, ... will include the general contact information, website, types of plans administered, years in business, ... business listing and have at least one plan with Employee Fiduciary. A search can ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2
... psychological tests on its recruits in a bid to control ... in the past few years, a defence scientist said Friday. ... October), we would be able to gauge the personality of ... the ratio of positive to negative traits," Manas Kumar Mandal, ...
... recently launched Chest Pain Clinics in the city would make ... ,The hospital launched a number of Chest Pain Clinics ... loss of time in order to save lives. ... 'The first few hours after the heart attack is the ...
... reactions to newer iodine-containing contrast agents (nonionic contrast media), ... study conducted by researchers from the University of Michigan ... Ann Arbor. ,'A major, if not the ... types of reactions. Such reactions can be mild; for ...
... why overweight elderly adults have low levels of vitamin D ... USDA Human Nutrition Research Center on Aging at Tufts University ... not account for low levels of vitamin D in elders ... high percent body fat have lower levels of 25-hydroxyvitamin D, ...
... muscle that separates the chest cavity from the abdominal ... birth defect known as congenital diaphragmatic hernia (CDH), results ... allows abdominal organs to migrate into the chest cavity. ... CDH, and in fact is the major predictor of ...
... are heaving a sigh of relief. The much-awaited double lung ... ,The 50-year-old man, as yet unnamed, is stable at the ... say confidently he has come through safely. ,It ... surgeons that is. A team at University of Michigan Health ...
Cached Medicine News:Health News:Army to Conduct Psychological Tests During Recruits to Curb Suicides 2Health News:Newer Contrast Agents Safe for Children 2Health News:Lack of Sun Does Not Explain Low Vitamin D in Elderly Who are Overweight 2Health News:Understanding and Treating Congenital Diaphragmatic Hernia 2Health News:Understanding and Treating Congenital Diaphragmatic Hernia 3Health News:Understanding and Treating Congenital Diaphragmatic Hernia 4Health News:Double Lung Transplant Man in Michigan Recovering 2
... Splints provide finger stability and control motion ... and loss of control due to stroke ... from translucent, neutral-tone plastic with broad bands ... design makes them the most versatile ring ...
... duty, controlled stretch knee support that helps ... full range of motion. The medial ... knee, and help to keep the elastic ... This is an excellent support for post-surgical ...
... to breathable foam. Three piece design for ... with loop closures. Lightweight rigid posterior stays ... ,Available with optional hot and cold therapy ... the pain cycle by providing cold therapy ...
... the outstanding features of our Neomax Premium ... Technology. , This manufacturing process allows us ... the bunching and irritation in the popliteal ... , ,Colors available: Blue, Black. ...
Medicine Products: